Breast Cancer
Showing NaN - NaN of 177
Metastatic Triple-Negative Breast Carcinoma, Breast Cancer Trial in Dallas (Neratinib Oral Tablet, Ruxolitinib Oral Tablet)
Not yet recruiting
- Metastatic Triple-Negative Breast Carcinoma
- Breast Cancer
- Neratinib Oral Tablet
- Ruxolitinib Oral Tablet
-
Dallas, TexasBaylor University Medical Center, Baylor Charles A Sammons Cance
Aug 22, 2023
Breast Cancer Trial in United States (Placebo, GLSI-100)
Recruiting
- Breast Cancer
- Placebo
- GLSI-100
-
Birmingham, Alabama
- +21 more
Jan 30, 2023
Triple Negative Breast Cancer, Breast Cancer Trial in United States (Trilaciclib, Cylophosphamide, Doxorubicin)
Active, not recruiting
- Triple Negative Breast Cancer
- Breast Cancer
- Trilaciclib
- +5 more
-
Los Alamitos, California
- +6 more
Jan 25, 2023
Breast Cancer Trial in Dallas (Digital Mammography, Low Osmolar Contrast Material, 300-399 Mg/Ml Iodine Concentration, Per Ml)
Active, not recruiting
- Breast Cancer
- Digital Mammography
- Low Osmolar Contrast Material, 300-399 Mg/Ml Iodine Concentration, Per Ml
-
Dallas, TexasUT Southwestern Medical Center
Jan 2, 2023
Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)
Active, not recruiting
- Advanced Cancer
- +16 more
-
Scottsdale, Arizona
- +3 more
Dec 22, 2022
Breast Cancer Trial in Dallas
Enrolling by invitation
- Breast Cancer
-
Dallas, TexasSusan G. Komen
Dec 8, 2022
NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in Canada, United States (PF-06946860, Placebo for PF-06946860)
Completed
- Non-small Cell Lung Cancer
- +9 more
- PF-06946860
- Placebo for PF-06946860
-
Little Rock, Arkansas
- +32 more
Dec 12, 2022
Breast Cancer Female, Breast Tumor Female Trial in United States (SV-BR-1-GM, INCMGA00012, Low dose cyclophosphamide)
Recruiting
- Breast Cancer
- +3 more
- SV-BR-1-GM
- +3 more
-
Newport Beach, California
- +9 more
Dec 8, 2022
Breast Cancer Trial in Greece, Israel, United States (MammaPrint, BluePrint, and Full-Genome Testing)
Recruiting
- Breast Cancer
- MammaPrint, BluePrint, and Full-Genome Testing
-
Birmingham, Alabama
- +117 more
Dec 1, 2022
Breast Cancer Trial in Dallas (Radiomics on MRI)
Recruiting
- Breast Cancer
- Radiomics on MRI
-
Dallas, TexasUniversity of Texas Southwestern Medical Center - Dallas
Nov 28, 2022
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022
Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single
Recruiting
- Advanced Solid Tumor
- +7 more
- PY159 Single agent dose level 1
- +17 more
-
San Francisco, California
- +11 more
Nov 3, 2022
TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)
Active, not recruiting
- TNBC - Triple-Negative Breast Cancer
- Breast Cancer
- Trilaciclib
- +3 more
-
Birmingham, Alabama
- +111 more
Oct 25, 2022
Breast Cancer Trial in Boston, Pittsburgh, Dallas (Nivolumab, Ipilimumab)
Active, not recruiting
- Breast Cancer
-
Boston, Massachusetts
- +2 more
Oct 21, 2022
Breast Cancer Trial in United States (Selene)
Recruiting
- Breast Cancer
- Selene
-
Tampa, Florida
- +7 more
Oct 12, 2022